Can-Fite BioPharma (CANF) Current Leases (2019 - 2025)
Can-Fite BioPharma's (CANF) quarterly Current Leases came in at $56000.0 in Q4 2025, up 5.66% YoY from $53000.0 in Q4 2024, and down 1.75% on a QoQ basis from $57000.0 in Q2 2025.
Can-Fite BioPharma (CANF) Current Leases (2019 - 2025) Analysis & Trends
Can-Fite BioPharma (CANF) has 7 years of Current Leases data on file, last reported at $56000.0 in Q4 2025.
- Quarterly Current Leases rose 5.66% year-over-year to $56000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $56000.0 (up 5.66% YoY) and the FY2025 annual result came in at $56000.0, up 5.66% from the prior year.
- Current Leases retreated to $56000.0 in Q4 2025, from $57000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $57000.0 in Q2 2025 to a low of $27000.0 in Q4 2023.
- A 5-year average of $45250.0 and a median of $45500.0 in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases plunged 43.75% — and 2024, when it soared 96.3%.
- Tracing CANF's Current Leases over 5 years: stood at $53000.0 in 2021, then slipped by 9.43% to $48000.0 in 2022, then sank by 43.75% to $27000.0 in 2023, then jumped by 96.3% to $53000.0 in 2024, then grew by 5.66% to $56000.0 in 2025.
- The last three Current Leases figures came in at $56000.0 (Q4 2025), $57000.0 (Q2 2025), and $53000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - | - |
| 10 | Can-Fite BioPharma | 2.78 Mn | -8.77 Mn | - | 56,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 56,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Dec 31, 2024 | 53,000.00 |
| Jun 30, 2024 | 36,000.00 |
| Dec 31, 2023 | 27,000.00 |
| Sep 30, 2023 | 34,000.00 |
| Jun 30, 2023 | 44,000.00 |
| Mar 31, 2023 | 42,000.00 |
| Dec 31, 2022 | 48,000.00 |
| Sep 30, 2022 | 48,000.00 |
| Jun 30, 2022 | 47,000.00 |
| Mar 31, 2022 | 55,000.00 |
| Dec 31, 2021 | 53,000.00 |
| Sep 30, 2021 | 40,000.00 |
| Jun 30, 2021 | 43,000.00 |
| Mar 31, 2021 | 41,000.00 |
| Dec 31, 2020 | 43,000.00 |
| Jun 30, 2020 | 36,000.00 |
| Dec 31, 2019 | 36,000.00 |